Hostname: page-component-89b8bd64d-dvtzq Total loading time: 0 Render date: 2026-05-10T16:16:22.281Z Has data issue: false hasContentIssue false
  • English
  • Français

Trait emotional experience in individuals with schizophrenia and youth at clinical high risk for psychosis

Published online by Cambridge University Press:  10 September 2019

Claire I. Yee Open the ORCID record for Claire I. Yee [Opens in a new window] ,
Gregory P. Strauss ,
Daniel N. Allen ,
Claudia M. Haase ,
David Kimhy  and
Vijay A. Mittal
Claire I. Yee*
Affiliation:
Postdoctoral Fellow, Department of Psychology and School of Education and Social Policy, Northwestern University, USA
Gregory P. Strauss
Affiliation:
Assistant Professor, Department of Psychology, University of Georgia, USA
Daniel N. Allen
Affiliation:
Director of Clinical Training, Department of Psychology, University of Nevada, USA
Claudia M. Haase
Affiliation:
Assistant Professor, School of Education and Social Policy, Northwestern University, USA
David Kimhy
Affiliation:
Associate Professor, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, USA
Vijay A. Mittal
Affiliation:
Associate Professor, Department of Psychology, Northwestern University, USA
*
Correspondence: Claire Yee, Department of Psychology, Northwestern University, Swift Hall 102, 2029 Sheridan Road, Evanston, IL 60201, USA. Email: claire.yee@northwestern.edu
Rights & Permissions [Opens in a new window]

Abstract

Background

Disturbances in trait emotions are a predominant feature in schizophrenia. However, less is known about (a) differences in trait emotion across phases of the illness such as the clinical high-risk (CHR) phase and (b) whether abnormalities in trait emotion that are associated with negative symptoms are driven by primary (i.e. idiopathic) or secondary (e.g. depression, anxiety) factors.

Aims

To examine profiles of trait affective disturbance and their clinical correlates in individuals with schizophrenia and individuals at CHR for psychosis.

Method

In two studies (sample 1: 56 out-patients diagnosed with schizophrenia and 34 demographically matched individuals without schizophrenia (controls); sample 2: 50 individuals at CHR and 56 individuals not at CHR (controls)), participants completed self-report trait positive affect and negative affect questionnaires, clinical symptom interviews (positive, negative, disorganised, depression, anxiety) and community-based functional outcome measures.

Results

Both clinical groups reported lower levels of positive affect (specific to joy among individuals with schizophrenia) and higher levels of negative affect compared with controls. For individuals with schizophrenia, links were found between positive affect and negative symptoms (which remained after controlling for secondary factors) and between negative affect and positive symptoms. For individuals at CHR, links were found between both affect dimensions and both types of symptom (which were largely accounted for by secondary factors).

Conclusions

Both clinical groups showed some evidence of reduced trait positive affect and elevated trait negative affect, suggesting that increasing trait positive affect and reducing trait negative affect is an important treatment goal across both populations. Clinical correlates of these emotional abnormalities were more integrally linked to clinical symptoms in individuals with schizophrenia and more closely linked to secondary influences such as depression and anxiety in individuals at CHR.

Declaration of interest

None.

Keywords

Psychosisprodromeemotionnegative symptoms

Information

Type
Papers
Information
BJPsych Open , Volume 5 , Issue 5 , September 2019 , e78
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Royal College of Psychiatrists 2019

Emotional abnormalities have been a core aspect of schizophrenia since the earliest conceptualisations of the disorder. For example, Kraepelin described individuals with schizophrenia as having ‘a weakening of those emotional activities which permanently form the mainsprings of volition’.Reference Kraepelin1 Bleuler similarly emphasised that individuals with schizophrenia were ‘disturbed in a number of ways, but above all the breakdown of the emotion’.Reference Kraepelin1 Modern empirical studies support these early observations by documenting abnormalities in a variety of emotional processes, such as facial and vocal expressivity, emotion perception, emotion regulation and trait emotional experience;Reference Herbener, Song, Khine and Sweeney2–Reference Yan, Cao, Zhang, Song, Cheung and Chan6 however, some emotional processes appear to be intact (e.g. state positive emotional experience).Reference Cohen and Minor7–Reference Strauss and Gold9 Importantly, when abnormalities are present in the aforementioned processes, they are consistently linked to poor clinical outcomes, such as increased severity of positive, negative and disorganised symptoms, poor community-based functional outcome and lower quality of life.Reference Edwards, Jackson and Pattison10–Reference Yamauchi, Aki, Tomotake, Iga, Numata and Motoki14

Although emotional abnormalities are clinically important in the active phases of schizophrenia, it is unclear whether they are also associated with liability for the illness. Psychotic disorders are typically preceded by a prodromal (i.e. pre-illness) phase characterised by functional decline and subtle attenuated hallucinations and delusions that progressively worsen over the course of several months to years.Reference Fusar-Poli, Bonoldi, Yung, Borgwardt, Kempton and Valmaggia15,Reference Yung, Yuen, Berger, Francey, Hung and Nelson16 This period is of interest both as a window for investigating processes involved in illness onset and as a potential point of intervention and prevention.Reference Addington, Cornblatt, Cadenhead, Cannon, McGlashan and Perkins17,Reference Schmidt, Schultze-Lutter, Schimmelmann, Maric, Salokangas and Riecher-Rössler18 Documenting the nature of emotional abnormalities among individuals at clinical high risk (CHR) for psychosis is critical for enhancing early identification and intervention efforts.Reference Corcoran, Kimhy, Parrilla-Escobar, Cressman, Stanford and Thompson19,Reference Velligan and Gonzalez20

Trait emotional experience studies in schizophrenia

Trait emotional experience (i.e. dispositional tendencies to experience positive or negative emotions in response to life's events in enduring and predictable waysReference Feldman Barrett and Russell21) is a critical aspect of emotionality that has received relatively little attention in the CHR literature. Studies administering trait emotional experience questionnaires to healthy individuals typically identify two distinct dimensions that are only moderately correlated: positive and negative affect.Reference Watson, Clark and Tellegen22 These dimensions predict mental and physical health for a number of conditions.Reference Mineka, Watson and Clark23,Reference Watson, Clark and Harkness24 A large number of studies administering trait questionnaires to individuals with schizophrenia indicate that they report lower levels of general positive affect and higher levels of general negative affect than individuals without schizophrenia (for a review see Horan et al Reference Horan, Blanchard, Clark and Green11). Differences in discrete trait emotions can also be observed between individuals with schizophrenia and those without. For example, individuals with schizophrenia report lower levels of trait joy and higher levels of trait fear and disgust and these differences are greatest for those with high levels of anhedonia and blunted affect.Reference Suslow, Roestel, Ohrmann and Arolt25 In a more general vein, low trait positive affect in schizophrenia has been linked to lower quality of life, smaller social networks, depression, anxiety and anhedonia.Reference Blanchard, Mueser and Bellack26–Reference Kentros, Terkelsen, Hull, Smith and Goodman28 The association between lower levels of positive affect and negative symptoms is particularly strong across studies.Reference Gooding and Tallent29–Reference Watson and Naragon-Gainey32 Conversely, high trait negative affect in schizophrenia has been linked to worse coping, occupational and social functioning, lower satisfaction with life, as well as increased smoking, alcohol and drug use.Reference Kentros, Terkelsen, Hull, Smith and Goodman28,Reference Blanchard, Squires, Henry, Horan, Bogenschutz and Lauriello33–Reference Lysaker and Taylor36

To our knowledge, only one study has evaluated trait positive and negative affect in individuals at CHR for psychosis. Seo and colleaguesReference Seo, Bang, Lee and An37 found that individuals at CHR reported lower levels of trait positive and higher levels of trait negative affect. Moreover, only negative symptoms predicted individual differences in both higher negative and lower positive trait affect.

Taken together, these findings suggest that trait affect may be critically related to negative symptoms in both individuals with schizophrenia and individuals at CHR for psychosis. However, negative symptoms are heterogeneous and it is possible for two participants to receive exactly the same score on a rating scale for different reasons. In schizophrenia, it is well-documented that negative symptoms can reflect both primary (i.e. idiopathic) and secondary (e.g. depression, anxiety) factors.Reference Kirkpatrick, Buchanan, Ross and Carpenter38 Individuals with schizophrenia with primary and enduring negative symptoms have clinical, biological and emotional profiles that are distinct from individuals with secondary negative symptoms or those with low levels of negative symptoms.Reference Kirkpatrick and Galderisi39–Reference Strauss, Jetha, Ross, Duke and Allen42 Secondary negative symptom sources (e.g. depression, anxiety) are also prominent in individuals at CHRReference Piskulic, Addington, Cadenhead, Cannon, Cornblatt and Heinssen43 and are strongly associated with negative symptoms;Reference Pelletier-Baldelli, Strauss, Visser and Mittal44 however, secondary negative symptoms tend to be transient, resolving with alleviation of the secondary influence. In contrast, primary negative symptoms tend to be persistent during the prodromal period, and can be identified at rates comparable to those in chronic schizophrenia (~33%).Reference Azar, Pruessner, Baer, Iyer, Malla and Lepage45 These findings suggest that clarifying the extent to which trait affective abnormalities are linked to primary and secondary negative symptoms across phases of illness is of critical importance because it would suggest how treatment efforts would be best directed at each stage.

The current study

The current study administered a trait emotional experience questionnaire and measures of clinical outcomes to cross-sectional samples of out-patients with schizophrenia and at CHR for psychosis to examine profiles of trait affective disturbance and their clinical correlates. The following hypotheses were tested: (a) both individuals with schizophrenia and those at CHR for psychosis would evidence diminished trait positive affect and elevated trait negative affect compared with control groups; (b) lower trait positive affect would be associated with increased severity of negative symptoms and poorer community-based functional outcome across both the sample with schizophrenia and the sample at CHR; and (c) higher trait negative affect would be associated with increased severity of positive and negative symptoms and poorer community-based functioning across both the samples with schizophrenia and the sample at CHR.

Prior psychosis studies have administered measures that were not amenable to examining the role of discrete emotions; however, examination of discrete emotions is an important extension because individual positive (e.g. joy, interest) and negative (e.g. sadness, fear) emotions can have unique effects on physiology, health and behaviour.Reference Goetz, Frenzel, Stoeger and Hall46–Reference Stellar, John-Henderson, Anderson, Gordon, McNeil and Keltner48 We therefore conducted exploratory analyses to determine whether individuals with schizophrenia and those at CHR showed different patterns of abnormalities on discrete trait emotions. Exploratory analyses were also conducted to determine whether associations between negative symptoms and trait affect reflected secondary factors in the samples with schizophrenia and at CHR. These analyses focused on depression, anxiety and antipsychotics as the most common secondary factors that are prevalent in both populations with schizophrenia and those at CHR.Reference Kirkpatrick, Buchanan, Ross and Carpenter38,Reference Piskulic, Addington, Cadenhead, Cannon, Cornblatt and Heinssen43 Negative symptoms do not reflect a singular construct,Reference Blanchard and Cohen49 but rather two broad dimensions reflecting diminished expressivity and diminished motivation and pleasure, or five discrete domains reflecting anhedonia, avolition, asociality, alogia and blunted affect.Reference Ahmed, Kirkpatrick, Galderisi, Mucci, Rossi and Bertolino50–Reference Strauss, Nuñez, Ahmed, Barchard, Granholm and Kirkpatrick52 Therefore, exploratory analyses examined associations between trait affect and the two broad negative symptom dimensions, as well as the five domains.

Method

The samples used for the study originate from two separate studies. Both studies were approved by the local institutional review boards, and written informed consent or assent was obtained from all participants.

Sample 1

Participants

Sample 1 comprised 56 individuals meeting DSM-IV-TR53 criteria for schizophrenia (79%) or schizoaffective disorder (21%) and 34 individuals without schizophrenia (controls). Individuals with schizophrenia were recruited from out-patient psychiatric mental health facilities and evaluated during periods of clinical stability, as determined by a minimum of 4 weeks of consistent medication dose and type or, in the absence of medication, deemed clinically stable by their treating clinician, as indicated by no significant changes in symptoms or functioning within the previous month. Consensus diagnosis was established via a best-estimate approach based on psychiatric history and multiple interview and subsequently confirmed using the Structured Clinical Interview for DSM-IV (SCID-IReference First, Spitzer, Gibbon and Williams54). All individuals with schizophrenia met DSM-IV current diagnostic criteria for schizophrenia or schizoaffective disorder; 93% were prescribed antipsychotic medications at the time of testing. Individuals without schizophrenia were recruited through posted advertisements and word of mouth among enrolled participants. All individuals without schizophrenia underwent a screening interview, including the SCID-I, and did not meet lifetime criteria for a psychotic disorder or any current Axis I disorder. Individuals without schizophrenia also had no self-reported family history of psychosis. The SCID-I was used to determine that no participants met DSM-IV criteria for substance misuse or dependence over the previous 6 months. All participants were also screened for lifetime neurological disorders and were free from neurological conditions (e.g. traumatic brain injury, epilepsy). Demographic details for sample 1 are given in Table 1.

Table 1

Demographic details for sample 1

SZ, schizophrenia; DES, Differential Emotions Scale IV-A; CPZeq, chlorpromazine equivalents; BPRS, Brief Psychiatric Rating Scale; GAF, Global Assessment of Functioning; SAPS, Scale for the Assessment of Positive Symptoms; SANS, Scale for the Assessment of Negative Symptoms.

a. Symptom domains are represented as the sum score of items for each specific category (positive and negative).

Measures

Clinical interviews

The Scale for the Assessment of Positive Symptoms (SAPS)Reference Andreasen55 and Negative Symptoms (SANS)Reference Andreasen56 were administered by clinical psychology doctoral students trained to reliability standards (α > 0.80) to measure participants' positive and negative symptoms. The Brief Psychiatric Rating Scale (BPRS)Reference Overall and Gorham57 was used to assess anxiety and depression. The Global Assessment of Functioning (GAF) score was used as a gross measure of global functioning.

Trait emotional experience

The Differential Emotions Scale IV-A (DES)Reference Izard, Libero, Putnam and Haynes58 is a 30-item self-report measure designed to assess the frequency with which individuals experience discrete basic emotions in everyday life. The questionnaire yields ten basic emotion scales (each measured by three items), with three scales representing positive emotions (joy, interest and surprise), which are averaged to measure positive affect (α = 0.73), and seven representing negative emotions (sadness, anger, fear, disgust, contempt, guilt and shame), which are averaged to measure negative affect (α = 0.91). Participants are required to identify the frequency with which they experience 30 emotions on a 5-point scale (1, rarely or never experienced; 5, experienced very often). DES items reflect verbal labels commonly applied to identify facial expressions, as well as current theories of basic emotion, which describe emotions in terms of discrete categories.Reference Izard59 This measure has been used in previous schizophrenia investigations, and demonstrated differences in experience among discrete emotions in individuals with and without schizophrenia.Reference Suslow, Roestel, Ohrmann and Arolt25

Sample 2

Participants

Sample 2 comprised a group of 50 adolescents and young adults aged between 13 and 21 years (mean 19.06, s.d. = 2.28) at CHR for psychosis and 56 matched individuals not at CHR (controls) recruited to the Adolescent Development and Preventive Treatment (ADAPT) research programme using internet, newspaper and public transportation advertisements, email postings and community professional referrals. Individuals at CHR in the present study met Structured Interview for Prodromal Syndromes (SIPS) criteria for a prodromal syndrome, defined by moderate-to-severe but not psychotic levels of positive symptoms (rated between 3 and 5 on a 6-point scale) or a decline in global functioning accompanying the presence of schizotypal personality disorder or a family history of schizophrenia.Reference Miller, McGlashan, Rosen, Cadenhead, Ventura and McFarlane60 Family history of psychosis was obtained by asking participants whether any first-degree family members had been diagnosed with a psychotic disorder. In most cases, family history was corroborated by another family member of the participant. Exclusion criteria consisted of head injury, the presence of a neurological disorder and lifetime substance dependence. The presence or lifetime history of an Axis I psychotic disorder at baseline was also an exclusion criterion for control and CHR status. See Table 2 for demographic information.

Table 2

Demographic details for sample 2

CHR, clinical high risk for psychosis; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; GFS, Global Functioning Scale; SIPS, Structured Interview for Prodromal Syndromes.

a. Parental education is the average of the mother's and father's education.

b. Symptom domains are represented as the total score of items for each specific category.

Measures

Clinical interviews

Interviews were administered by expert raters trained to reliability standards (α > 0.80). The SIPS was administered at baseline to diagnose a prodromal syndrome and assess symptoms.Reference Miller, McGlashan, Rosen, Cadenhead, Ventura and McFarlane60,Reference McGlashan, Walsh and Woods61 A total sum score for the positive, negative and disorganised symptom domains is used as an indicator of the respective dimensions of symptomatology.

Depression and anxiety were assessed using the Beck Depression Inventory (BDI)Reference Beck, Steer and Brown62 and the Beck Anxiety Inventory (BAI).Reference Beck, Epstein, Brown and Steer63

The Global Functioning Scale: Social (GFS-S) and Role (GFS-R)Reference Cornblatt, Auther, Niendam, Smith, Zinberg and Bearden64 were used to assess community-based functional outcome (e.g. number of friends, how often the individual engages in social activity, performance at school, work). A score is given on a 1–10 scale, with 1 indicating low levels of functioning and 10 indicating very high levels of functioning.

Trait emotional experience

The Modified Differential Emotions Scale (mDES)Reference Fredrickson, Tugade, Waugh and Larkin65 was used to measure trait emotional experience. Participants rated the extent to which they felt each of 20 emotions on average or in general on a 5-point scale from 0 (not at all) to 4 (extremely). The mDES differs from the DES in that it measures each emotion with a single item, thus increasing the number of discrete positive emotions from three to ten. The ten positive emotions (amusement, awe, content, joy, gratitude, hope, interest, love, pride and surprise) were averaged together to form the positive affect composite (α = 0.88). The negative affect composite averaged scores for anger, shame, fear, disgust, embarrassment, guilt, sadness and contempt (α = 0.93).

Data analytic strategy

Repeated measures ANOVAs were used to test differences in the pattern of self-reported emotional experience among clinical and control samples. Each ANOVA had two groups (schizophrenia/CHR, control) with two emotion dimensions (positive, negative). Significant interactions were followed up with one-way ANOVAs and within-group paired samples t-tests.

Correlations were analysed to examine the relationship between emotionality, symptoms and functioning in the individuals with schizophrenia and those at CHR. In the first set of correlations, emotionality included the positive and negative affect composites, symptoms included positive and negative totals (and disorganised for sample 2) and functionality included the GAF for sample 1 and GFS-S and GFS-R for sample 2. In the second set of correlations, negative symptoms were broken into two subsets: two subdimensions (i.e. diminished expression and diminished motivation in individuals with schizophrenia, and diminished emotion and diminished volition in individuals at CHR),Reference Strauss, Horan, Kirkpatrick, Fischer, Keller and Miski66,Reference Azis, Strauss, Walker, Revelle, Zinbarg and Mittal67 and the five National Institute of Mental Health (NIMH) negative symptom domains (i.e. anhedonia, avolition, asociality, alogia and blunted affect).Reference Kirkpatrick, Fenton, Carpenter and Marder68 To test the extent to which relationships in this second set of correlations were influenced by secondary factors, partial correlations were run controlling for depression and anxiety (and antipsychotics in sample 1). In sample 2, all partial correlations were re-run excluding individuals on antipsychotics. No correlations changed significantly in magnitude or direction when excluding these individuals. The Benjamini–Hochberg correction procedure was used for each set of correlations to control for multiple correlation tests.Reference Benjamini and Hochberg69 Results of the procedure are stated at the end of each correlation section.

Results

Group differences in trait emotional experience

Affect differences between individuals with and without schizophrenia

A repeated-measures ANOVA was conducted to test for group differences in trait emotional experience between individuals with and without schizophrenia. There was a statistically significant group × emotion interaction, in addition to a main effect of group and a within-participants effect of emotion. Follow-up one-way ANOVAs showed higher levels of negative emotion in individuals with schizophrenia compared with individuals without schizophrenia, but no group differences in positive emotion. Paired-samples t-tests showed higher levels of positive than negative emotion within each group (Table 3; Fig. 1).

Fig. 1

Differences in positive and negative affect in samples 1 and 2.

Bars in each graph represent standard error. SZ, individuals with schizophrenia; CHR, individuals at clinical high risk for psychosis.
Table 3

Omnibus ANOVA and post hoc results for group affect differences

SZ, individuals with schizophrenia; CHR, individuals at clinical high risk for psychosis.

Affect differences between individuals at CHR and not at CHR

A repeated-measures ANOVA showed a significant group × emotion interaction, in addition to a main effect of group and a within-participants effect of emotion. Follow-up one-way ANOVAs showed lower levels of positive and higher levels of negative affect in individuals at CHR for psychosis compared with individuals not at CHR. Paired-samples t-tests showed higher levels of positive than negative emotion within each group (Table 3; Fig. 1).

Exploratory discrete emotion differences between both samples

Across samples, both repeated-measures ANOVAs showed a significant group × emotion interaction and a within-participants effect of emotion. Follow-up one-way ANOVAs showed that in sample 1, two of the three positive emotions (i.e. joy and surprise) showed significant differences between individuals with and without schizophrenia. For joy, individuals with schizophrenia reported lower joy than individuals without schizophrenia, whereas individuals with schizophrenia reported more surprise compared with individuals without schizophrenia. However, after correcting for multiple tests, these two differences between groups were not significant. Four of the eight negative emotions (i.e. shame, fear, disgust and sadness) showed marginal or significant differences (Table 4), whereas the other four (i.e. anger, guilt, contempt and hostility) showed no significant differences between individuals with and without schizophrenia. In sample 2, seven of the ten positive emotions (i.e. amusement, contentment, joy, gratitude, hope, love and pride) and each of the eight negative emotions (i.e. anger, shame, fear, disgust, embarrassment, guilt, sadness and contempt) showed significant differences between individuals at and not at CHR for psychosis (Fig. 2). In all cases, individuals at CHR reported more negative emotions than individuals not at CHR. All group differences remained unchanged after correcting for multiple testing, except for the findings for joy and surprise in sample 1.

Fig. 2

Differences in discrete emotions in samples 1 and 2.

In sample 1, group differences for joy and surprise did not meet multiple testing correction criteria. SZ, individuals with schizophrenia; CHR, individuals at clinical high risk for psychosis.
Table 4

Omnibus ANOVAs and post hoc results for discrete trait emotions

a. The finding did not meet multiple testing correction criteria.

Trait emotional experience and clinical and functional outcomes

Affect relationships to symptoms and functioning in individuals with schizophrenia

Pearson correlations were conducted to investigate the degree to which positive and negative emotions were related to clinical symptoms and functional outcomes in the individuals with schizophrenia. Lower levels of positive affect were related to higher levels of negative symptoms but were not significantly related to positive symptoms. Higher levels of negative affect were related to higher levels of positive symptoms and were unrelated to negative symptoms. Neither type of emotion was directly related to functioning (Fig. 3). All relationships remained unchanged after correcting for multiple correlation tests.

Fig. 3

Correlations between affect, clinical symptoms and functioning in samples 1 and 2.

Pos, positive; Neg, negative; Emo, affect; SAPS, Scale for the Assessment of Positive Symptoms; SANS, Scale for the Assessment of Negative Symptoms; GAF, Global Assessment of Functioning; SIPS, Structured Interview for Prodromal Syndromes; Dis, disorganized symptoms; GFS, Global Functioning Scale.

Affect relationships to symptoms and functioning in individuals at CHR

Correlations in the individuals at CHR for psychosis showed that lower levels of positive affect were related to higher levels of both positive and negative symptoms. Higher levels of negative affect were related to higher levels of positive, negative and disorganised symptoms. Positive affect was positively associated with social functioning, and negative affect was negatively associated with negative role functioning. Higher levels of SIPS symptoms were all related to lower levels of social and role functioning (Fig. 3, right panel). All relationships remained unchanged after correcting for multiple correlation tests.

Exploratory affect relationships to negative symptom subtypes in individuals with schizophrenia and at CHR

To further explore the relationship between affect and negative symptoms in individuals with schizophrenia, negative symptoms were decomposed in two sets of analyses: the two subdimensions of expressivity and motivation, and the five NIMH domains. When examining the two subdimensions of negative symptoms, strong relationships between diminished motivation and both positive affect and negative affect emerged, whereas expressivity was only marginally related to positive affect and unrelated to negative affect. When examining negative symptoms using the NIMH domains, correlation analyses showed that positive affect was significantly negatively related to all NIMH domains except alogia, and only marginally related to blunted affect. The relationship between negative affect and the five domains seemed more complex, with negative affect being significantly related only to anhedonia and marginally related to alogia and asociality (supplementary Table 1 available at https://doi.org/10.1192/bjo.2019.64). All relationships remained unchanged after correcting for multiple correlation tests.

The same two-dimension approach for negative symptoms in individuals at CHR for psychosis showed that higher levels of both dimensions of negative symptoms (i.e. diminished expressivity and diminished motivation) were related to lower levels of positive affect and higher levels of negative affect. In analysis of the individual SIPS items, every item was related to higher levels of negative affect, whereas positive affect was related only to the avolition, emotion expression and emotion experience items (supplementary Table 2). All relationships remained unchanged after correcting for multiple correlation tests.

Secondary negative symptom influences on trait emotional experience

Relationships between affect and negative symptoms controlling for anxiety, depression and antipsychotics in individuals with schizophrenia

After controlling for anxiety, depression and antipsychotic medication, only the relationship between positive affect and negative symptoms remained significant in individuals with schizophrenia. For the five NIMH domains, only the relationship between positive affect and the NIMH domains of avolition, anhedonia and asociality remained significant (supplementary Table 3). All relationships remained unchanged after correcting for multiple correlation tests.

Relationships between affect and negative symptoms controlling for anxiety and depression in individuals at CHR

After controlling for anxiety and depression, only the relationship between negative affect and diminished motivation remained significant in individuals at CHR for psychosis. Similarly, only the relationships between negative affect and the individual SIPS components remained significant when controlling for anxiety and depression (supplementary Table 4). All relationships remained unchanged after correcting for multiple correlation tests.

Discussion

In this study we observed that clinical samples of individuals with schizophrenia and individuals at CHR for psychosis showed differences from their respective controls in trait emotional experiences. Furthermore, differences in trait emotional experiences were closely linked to clinical symptoms and functional outcomes. This study was the first of its kind to examine differences in trait emotion across a wide set of emotions in individuals with schizophrenia and individuals at CHR. In individuals with schizophrenia, the relationship between the positive-emotion deficit and negative symptoms remained after controlling for secondary influences of depression and anxiety. In individuals at CHR, it is noteworthy that controlling for depression and anxiety eliminated the relationship between the positive-emotion deficit and negative symptoms. The following paragraphs discuss the implications of these findings.

Levels of trait positive and negative affect in schizophrenia

Individuals with schizophrenia reported higher levels of trait negative affect compared with individuals without schizophrenia, converging with prior literature,Reference Horan, Blanchard, Clark and Green11,Reference Suslow, Roestel, Ohrmann and Arolt25 including findings by Cohen & Minor,Reference Cohen and Minor7 who showed that individuals with schizophrenia are likely to report aversive reactions to positive and negative stimuli. The present study showed that negative affect was driven by disgust, fear and shame in particular, converging with findings by Birchwood & colleagues,Reference Birchwood, Meaden, Trower, Gilbert and Plaistow70 who showed that fear and shame specifically may drive avoidance behaviour in psychosis (and disgust has similar avoidance functions).Reference Rozin and Fallon71 No differences were found for other negative emotions (i.e. anger, guilt, contempt and hostility) or for global positive affect in the groups with and without schizophrenia. However, examining specific positive emotions revealed preliminary opposing effects for joy (which was reduced) and surprise (which was elevated) in individuals with schizophrenia. Although these results did not stand up to multiple test correction, they directionally support existing evidence of reduced positive trait affect in individuals with schizophrenia.Reference Horan, Blanchard, Clark and Green11,Reference Suslow, Roestel, Ohrmann and Arolt25,Reference Hooker, Benson, Gyurak, Yin, Tully and Lincoln72 When interpreting the directionally elevated levels of surprise in individuals with schizophrenia, it is important to consider that individuals typically do not perceive surprise as emotionally positive but rather as ambiguous or even negative.Reference Lorini and Castelfranchi73

Generalised emotion deficits in individuals at CHR

Individuals at CHR for psychosis showed a broad array of abnormalities in trait positive and negative emotional experiences. Specifically, individuals at CHR reported lower levels of seven out of ten positive emotions (i.e. lower levels of amusement, contentment, joy, gratitude, hope, love and pride; no differences in awe, interest and surprise) and higher levels of all negative emotions compared with individuals not at CHR. These findings highlight that the emotion deficits in individuals at CHR are fairly generalised. It should be noted that exploratory analyses revealed that, for those at CHR who converted to a psychosis syndrome (n = 3, from the original group of 50) during the 2-year follow-up period, emotional alterations were in the same direction as for the rest of the original group at CHR, with directionally lower levels of positive emotions (mean 1.50, s.d. = 0.36) and higher levels of negative emotions (mean 1.92, s.d. = 0.29) compared with controls. Although the small number of individuals who developed a psychosis syndrome does not allow for direct comparisons with the general group at CHR, this is an important question for future studies with larger samples.

Discrete emotions versus affective valence

Individuals with schizophrenia reported directionally different results for two of the three positive emotions (joy and surprise) and reported only some negative emotions as elevated. Although the differences in joy and surprise should be interpreted with caution, key significant findings remain (e.g. reports of higher levels of fear, shame and disgust, but not anger, guilt, contempt and hostility by individuals with schizophrenia compared with individuals without schizophrenia). These findings cumulatively emphasise the importance of moving beyond positive and negative affective valence toward considering discrete emotions (e.g. joy, surprise, fear, contempt), which may show unique patterns in individuals with schizophrenia and those at CHR for psychosis.

Association of trait emotional experiences with symptoms and functioning

Individuals with schizophrenia and individuals at CHR showed differences in relationships between trait emotional experiences on the one hand and clinical symptoms and functioning on the other. For individuals with schizophrenia, only positive affect was associated with negative symptoms, and only negative affect was associated with positive symptoms. These results support the stronger relationships reported in the literature between the positive-emotion deficit and negative symptoms.Reference Horan, Green, Kring and Nuechterlein31,Reference Watson and Naragon-Gainey32,Reference Freeman and Garety74 Reviews of negative emotions and negative symptoms yield unreliable associations between the two.Reference Horan, Blanchard, Clark and Green11 Exploring specific aspects of negative symptoms suggested that the absence of a relationship between negative affect and negative symptoms may be partly explained by the fact that only diminished motivation was related to abnormalities in both positive and negative affect. Additionally, analysing negative symptoms at the level of the five domains of negative symptoms (anhedonia, avolition, asociality, alogia and blunted affect) showed that positive affect was most closely associated with all five, again supporting the notion that negative symptoms are those most closely tied to the positive affect deficit. Although the absence of some of these relationships may be due to the small sample, these findings support existing literature that positive emotions are most closely associated with negative symptoms. Unlike prior research, neither type of affect predicted decreased functioning.Reference Blanchard, Mueser and Bellack26,Reference Cohen, Dinzeo, Nienow, Smith, Singer and Docherty27 However, both studies used measures that differed from previous research, as we used self-report rather than interviewer ratings and assessed the presence/absence of specific skills rather making normative assessments of functioning.

In individuals at CHR for psychosis, trait emotional experiences were highly interconnected with symptoms and functioning. Both positive and negative affect were linked to both positive and negative symptoms. Moreover, both positive and negative affect were linked to both negative symptom dimensions (i.e. diminished expressivity; diminished motivation and pleasure). When breaking these symptoms down into the five subdomains, negative affect was interconnected with more subdomains than positive affect. These findings add important specificity for studies showing links between emotions and negative symptoms.Reference Phillips and Seidman5,Reference Seo, Bang, Lee and An37 The breadth of interconnectedness between trait emotion, symptoms and functioning highlights not only the generalised pathology of emotion abnormalities in the population at CHR for psychosis, but also the importance of making emotions the target of interventions for improving functional outcomes.

Influence of secondary factors on trait emotional experience

Secondary negative influences have not been studied in individuals with schizophrenia. This study found that controlling for secondary influences left only the relationship between positive affect and negative symptoms intact. The resilience of this relationship to these influences supports hypotheses that trait emotion differences, in particular positive-emotion deficits, may be more closely linked to the core of schizophrenia.Reference Strauss and Gold9,Reference Cohen, Najolia, Brown and Minor75 Controlling for secondary influences in individuals at CHR for psychosis showed a strong relationship between negative affect and negative symptoms. These differences suggest that the emotion abnormalities (e.g. the positive-emotion deficit) seen in individuals at CHR may be driven more by a generalised psychopathology than the emotion abnormalities seen in individuals with schizophrenia. The concept of generalised psychopathology in individuals at CHR fits with recent findings that a high proportion of adolescents with anxiety and/or depression also display psychotic symptoms.Reference Wigman, van Nierop, Vollebergh, Lieb, Beesdo-Baum and Wittchen76 It is possible that this high comorbidity rate in individuals at CHR reflects a close link between emotion dysregulation and psychosis early on. These findings also fit with other studies showing that individuals at CHR often report first with anxiety disorders or depression.Reference Addington, Cornblatt, Cadenhead, Cannon, McGlashan and Perkins17,Reference Velthorst, Nieman, Becker, van de Fliert, Dingemans and Klaassen77 The current findings suggest that a subset of individuals at CHR may have a high rate of generalised vulnerability for developing psychopathology. Identifying unique markers of these subgroups within the population of individuals at CHR can help isolate outcome groups earlier when young people first seek treatment.

Limitations

The present findings should be viewed in light of several limitations of the study. The group of individuals with schizophrenia was relatively small and it may thus have been underpowered to detect smaller effects. Nevertheless, the group with schizophrenia in the current study was larger than every group with schizophrenia in one review of studies on emotion differences in schizophreniaReference Kring and Moran4 and larger than over two-thirds of groups in another review of trait emotion in schizophrenia.Reference Horan, Blanchard, Clark and Green11 Additionally, direct comparisons were limited between the individuals with schizophrenia and those at CHR for psychosis, as two different versions of the scale for measuring trait emotions were used for the two groups. Although exact parallels between the two groups cannot be drawn, both scales call attention to the importance of examining trait emotions at the discrete level, rather than always assuming generalisable effects for positive and negative affect. Literature showing that individuals with schizophrenia have a high degree of difficulty with emotional awareness suggests that caution should be used in interpreting strong differences between discrete emotions within the group with schizophrenia.Reference Addington, Cornblatt, Cadenhead, Cannon, McGlashan and Perkins17,Reference Van't Wout, Aleman, Bermond and Kahn78 However, the differences in some discrete emotions and not others found in the present study suggest that individuals with schizophrenia maintain some degree of differentiation. Future studies would benefit from examining how specific this level of differentiation is. Finally, differences in ages (e.g. adults with schizophrenia and adolescents and young adults at CHR) also limited direct comparisons between the two groups. However, the differences in age boost the external validity and generalisability of both samples.

Future research

Taken together, these findings suggest that trait emotion abnormalities are an important consideration in schizophrenia. Although the stability of trait emotional experience abnormalities has yet to be determined, such research is critical in determining whether trait affect should be the focus of psychosocial treatments such as cognitive–behavioural therapy for symptoms of the schizophrenia. Results also highlight the nuance that differentiating discrete emotions can add. Further, the present observations suggest that, although trait emotion abnormalities are implicated in both the prodrome and then later after onset, this critical domain may need to be assessed and conceptualised differently across stages of psychosis. Although examining trait emotion abnormalities in the prodrome is still in its early stages, early evidence highlights a hefty role for secondary influences. Experimental studies and large-scale longitudinal investigations will be instrumental in improving our understanding of this important area, and for driving early identification and treatment development efforts.

Funding

This work was supported by National Institutes of Health grants R01MH094650 and R21MH110374 to V.A.M, R21MH115231 to C.M.H. and V.A.M, and K23MH092530 to G.P.S.

Supplementary material

Supplementary material is available online at https://doi.org/10.1192/bjo.2019.64.

References

1Kraepelin, E. Dementia Praecox and Paraphrenia (trans RM Barclay, ed GM Robertson). Chicago Medical Book Co, 1919.Google Scholar
2Herbener, ES, Song, W, Khine, TT, Sweeney, JA. What aspects of emotional functioning are impaired in schizophrenia? Schizophr Res 2008; 98: 239–46.Google Scholar
3Kring, AM, Elis, O. Emotion deficits in people with schizophrenia. Annu Rev Clin Psychol 2013; 9: 409–33.Google Scholar
4Kring, AM, Moran, EK. Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull 2008; 34: 819–34.Google Scholar
5Phillips, LK, Seidman, LJ. Emotion processing in persons at risk for schizophrenia. Schizophr Bull 2008; 34: 888–903.Google Scholar
6Yan, C, Cao, Y, Zhang, Y, Song, LL, Cheung, EF, Chan, RC. Trait and state positive emotional experience in schizophrenia: a meta-analysis. PLoS One 2012; 7(7): e40672.Google Scholar
7Cohen, AS, Minor, KS. Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophr Bull 2008; 36: 143–50.Google Scholar
8Llerena, K, Strauss, GP, Cohen, AS. Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia. Schizophr Res 2012; 142: 65–70.Google Scholar
9Strauss, GP, Gold, JM. A new perspective on anhedonia in schizophrenia. Am J Psychiatry 2012; 169: 364–73.Google Scholar
10Edwards, J, Jackson, HJ, Pattison, PE. Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clin Psychol Rev 2002; 22: 789–832.Google Scholar
11Horan, WP, Blanchard, JJ, Clark, LA, Green, MF. Affective traits in schizophrenia and schizotypy. Schizophr Bull 2008; 34: 856–74.Google Scholar
12Kee, KS, Horan, WP, Salovey, P, Kern, RS, Sergi, MJ, Fiske, AP, et al. Emotional intelligence in schizophrenia. Schizophr Res 2009; 107: 61–8.Google Scholar
13Kimhy, D, Vakhrusheva, J, Jobson-Ahmed, L, Tarrier, N, Malaspina, D, Gross, JJ. Emotion awareness and regulation in individuals with schizophrenia: implications for social functioning. Psychiatry Res 2012; 200: 193–201.Google Scholar
14Yamauchi, K, Aki, H, Tomotake, M, Iga, JI, Numata, S, Motoki, I, et al. Predictors of subjective and objective quality of life in outpatients with schizophrenia. Psychiatry Clin Neurosci 2008; 62: 404–11.Google Scholar
15Fusar-Poli, P, Bonoldi, I, Yung, AR, Borgwardt, S, Kempton, MJ, Valmaggia, L, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012; 69: 220–9.Google Scholar
16Yung, AR, Yuen, HP, Berger, G, Francey, S, Hung, TC, Nelson, B, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007; 33: 673–81.Google Scholar
17Addington, J, Cornblatt, BA, Cadenhead, KS, Cannon, TD, McGlashan, TH, Perkins, D, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 2011; 168: 800–5.Google Scholar
18Schmidt, SJ, Schultze-Lutter, F, Schimmelmann, BG, Maric, NP, Salokangas, RKR, Riecher-Rössler, A, et al. EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry 2015; 30: 388–404.Google Scholar
19Corcoran, CM, Kimhy, D, Parrilla-Escobar, MA, Cressman, VL, Stanford, AD, Thompson, J, et al. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol Med 2011; 41: 251–61.Google Scholar
20Velligan, DI, Gonzalez, JM. Rehabilitation and recovery in schizophrenia. Psychiatr Clin North Am 2007; 30: 535–48.Google Scholar
21Feldman Barrett, L, Russell, JA. Independence and bipolarity in the structure of current affect. J Pers Soc Psychol 1998; 74: 967–84.Google Scholar
22Watson, D, Clark, LA, Tellegen, A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54: 1063.Google Scholar
23Mineka, S, Watson, D, Clark, LA. Comorbidity of anxiety and unipolar mood disorders. Annu Rev Psychol 1998; 49: 377–412.Google Scholar
24Watson, D, Clark, LA, Harkness, AR. Structures of personality and their relevance to psychopathology. J Abnorm Psychol 1994; 103: 18–31.Google Scholar
25Suslow, T, Roestel, C, Ohrmann, P, Arolt, V. The experience of basic emotions in schizophrenia with and without affective negative symptoms. Compr Psychiatry 2003; 44: 303–10.Google Scholar
26Blanchard, JJ, Mueser, KT, Bellack, AS. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull 1998; 24: 413–24.Google Scholar
27Cohen, AS, Dinzeo, TJ, Nienow, TM, Smith, DA, Singer, B, Docherty, NM. Diminished emotionality and social functioning in schizophrenia. J Nerv Ment Dis 2005; 193: 796–802.Google Scholar
28Kentros, MK, Terkelsen, K, Hull, J, Smith, TE, Goodman, M. The relationship between personality and quality of life in persons with schizoaffective disorder and schizophrenia. Qual Life Res 1997; 6: 118–22.Google Scholar
29Gooding, DC, Tallent, KA. Spatial, object, and affective working memory in social anhedonia: an exploratory study. Schizophr Res 2003; 63: 247–60.Google Scholar
30Horan, WP, Blanchard, JJ. Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping. Schizophr Res 2003; 60: 271–83.Google Scholar
31Horan, WP, Green, MF, Kring, AM, Nuechterlein, KH. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol 2006; 115: 496–508.Google Scholar
32Watson, D, Naragon-Gainey, K. On the specificity of positive emotional dysfunction in psychopathology: evidence from the mood and anxiety disorders and schizophrenia/schizotypy. Clin Psychol Rev 2010; 30: 839–48.Google Scholar
33Blanchard, JJ, Squires, D, Henry, T, Horan, WP, Bogenschutz, M, Lauriello, J, et al. Examining an affect regulation model of substance abuse in schizophrenia: the role of traits and coping. J Nerv Ment Dis 1999; 187: 72–9.Google Scholar
34Couture, S, Lecomte, T, Leclerc, C. Personality characteristics and attachment in first episode psychosis: impact on social functioning. J Nerv Ment Dis 2007; 195: 631–9.Google Scholar
35Horan, WP, Subotnik, KL, Reise, S, Ventura, J, Nuechterlein, KH. Personality characteristics in recent-onset schizophrenia: longitudinal stability and clinical correlates. Psychol Med 2005; 35: 995–1005.Google Scholar
36Lysaker, PH, Taylor, AC. Personality dimensions in schizophrenia: associations with symptoms and coping concurrently and 12 months later. Psychopathology 2007; 40: 338–44.Google Scholar
37Seo, E, Bang, M, Lee, E, An, SK. Aberrant tendency of noncurrent emotional experiences in individuals at ultra-high risk for psychosis. Psychiatry Investig 2018; 15: 876–83.Google Scholar
38Kirkpatrick, B, Buchanan, RW, Ross, DE, Carpenter, WT. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 2001; 58: 165–71.Google Scholar
39Kirkpatrick, B, Galderisi, S. Deficit schizophrenia: an update. World Psychiatry 2008; 7: 143–7.Google Scholar
40Strauss, GP, Allen, DN, Duke, LA, Ross, SA, Schwartz, J. Automatic affective processing impairments in patients with deficit syndrome schizophrenia. Schizophr Res 2008; 102: 76–87.Google Scholar
41Strauss, GP, Allen, DN, Ross, SA, Duke, LA, Schwartz, J. Olfactory hedonic judgment in patients with deficit syndrome schizophrenia. Schizophr Bull 2009; 36: 860–8.Google Scholar
42Strauss, GP, Jetha, SS, Ross, SA, Duke, LA, Allen, DN. Impaired facial affect labeling and discrimination in patients with deficit syndrome schizophrenia. Schizophr Res 2010; 118: 146–53.Google Scholar
43Piskulic, D, Addington, J, Cadenhead, KS, Cannon, TD, Cornblatt, BA, Heinssen, R, et al. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res 2012; 196: 220–4.Google Scholar
44Pelletier-Baldelli, A, Strauss, GP, Visser, KH, Mittal, VA. Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS). Schizophr Res 2017; 189: 43–9.Google Scholar
45Azar, M, Pruessner, M, Baer, LH, Iyer, S, Malla, AK, Lepage, M. A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis. Early Interv Psychiatry 2018; 12: 900–6.Google Scholar
46Goetz, T, Frenzel, AC, Stoeger, H, Hall, NC. Antecedents of everyday positive emotions: an experience sampling analysis. Motiv Emotion 2010; 34: 49–62.Google Scholar
47Pressman, SD, Jenkins, BN, Kraft-Feil, TL, Rasmussen, H, Scheier, MF. The whole is not the sum of its parts: specific types of positive affect influence sleep differentially. Emotion 2017; 17: 778–93.Google Scholar
48Stellar, JE, John-Henderson, N, Anderson, CL, Gordon, AM, McNeil, GD, Keltner, D. Positive affect and markers of inflammation: discrete positive emotions predict lower levels of inflammatory cytokines. Emotion 2015; 15: 129–33.Google Scholar
49Blanchard, JJ, Cohen, AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 2005; 32: 238–45.Google Scholar
50Ahmed, AO, Kirkpatrick, B, Galderisi, S, Mucci, A, Rossi, A, Bertolino, A, et al. Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia. Schizophr Bull 2018; 46: 3383–95.Google Scholar
51Strauss, GP, Esfahlani, FZ, Galderisi, S, Mucci, A, Rossi, A, Bucci, P, et al. Network analysis reveals the latent structure of negative symptoms in schizophrenia. Schizophr Bull 2018; Sep 26: doi 10.1093/schbul/sby133 [Epub ahead of print].Google Scholar
52Strauss, GP, Nuñez, A, Ahmed, AO, Barchard, KA, Granholm, E, Kirkpatrick, B, et al. The latent structure of negative symptoms in schizophrenia. JAMA Psychiatry 2018; 75: 1271–9.Google Scholar
53American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn text revision) (DSM-IV-TR). APA, 2000.Google Scholar
54First, MBSpitzer, RLGibbon, MWilliams, JB. Structured Clinical Interview for DSM-IV Axis I Disorders - Clinician Version (SCID-I/CV). American Psychiatric Press, 1996.Google Scholar
55Andreasen, NC. Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, 1984.Google Scholar
56Andreasen, NC. Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry 1989; 155: 53–8.Google Scholar
57Overall, JE, Gorham, DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799–812.Google Scholar
58Izard, C, Libero, D, Putnam, P, Haynes, O. Stability of emotion experiences and their relations to traits of personality. J Pers Soc Psychol 1993; 64: 847–60.Google Scholar
59Izard, CE. The Face of Emotion. Appleton-Century-Crofts, 1971.Google Scholar
60Miller, TJ, McGlashan, TH, Rosen, JL, Cadenhead, K, Ventura, J, McFarlane, W, et al. Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703–15.Google Scholar
61McGlashan, T, Walsh, BC, Woods, S. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up. Oxford University Press, 2010.Google Scholar
62Beck, AT, Steer, RA, Brown, GK. Manual for the Beck Depression Inventory-II. Psychological Corporation, 1996.Google Scholar
63Beck, AT, Epstein, N, Brown, G, Steer, RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893–7.Google Scholar
64Cornblatt, BA, Auther, AM, Niendam, T, Smith, CW, Zinberg, J, Bearden, C, et al. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull 2007; 33: 688–702.Google Scholar
65Fredrickson, BL, Tugade, MM, Waugh, CE, Larkin, G. What good are positive emotions in crises? A prospective study of resilience and emotions following the terrorist attacks on the United States on September 11th, 2001. J Pers Soc Psychol 2003; 84: 365–76.Google Scholar
66Strauss, GP, Horan, WP, Kirkpatrick, B, Fischer, BA, Keller, WR, Miski, P, et al. Deconstructing negative symptoms of schizophrenia: avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res 2013; 47: 783–90.Google Scholar
67Azis, M, Strauss, GP, Walker, E, Revelle, W, Zinbarg, R, Mittal, V. Factor analysis of negative symptom items in the Structured Interview for Prodromal Syndromes. Schizophr Bull 2018; Dec 8: doi 10.1093/schbul/sby177 [Epub ahead of print].Google Scholar
68Kirkpatrick, B, Fenton, WS, Carpenter, WT, Marder, SR, The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 2006; 32: 214–19.Google Scholar
69Benjamini, Y, Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995: 289–300.Google Scholar
70Birchwood, M, Meaden, A, Trower, P, Gilbert, P, Plaistow, J. The power and omnipotence of voices: subordination and entrapment by voices and significant others. Psychol Med 2000; 30: 337–44.Google Scholar
71Rozin, P, Fallon, AE. A perspective on disgust. Psychol Rev 1987; 94: 23–41.Google Scholar
72Hooker, CI, Benson, TL, Gyurak, A, Yin, H, Tully, LM, Lincoln, SH. Neural activity to positive expressions predicts daily experience of schizophrenia-spectrum symptoms in adults with high social anhedonia. J Abnorm Psychol 2014; 123: 190–204.Google Scholar
73Lorini, E, Castelfranchi, C. The cognitive structure of surprise: looking for basic principles. Topoi 2007; 26: 133–49.Google Scholar
74Freeman, D, Garety, PA. Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations. Behav Res Ther 2003; 41: 923–47.Google Scholar
75Cohen, AS, Najolia, GM, Brown, LA, Minor, KS. The state-trait disjunction of anhedonia in schizophrenia: potential affective, cognitive and social-based mechanisms. Clin Psychol Rev 2011; 31: 440–8.Google Scholar
76Wigman, JT, van Nierop, M, Vollebergh, WA, Lieb, R, Beesdo-Baum, K, Wittchen, HU, et al. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity: implications for diagnosis and ultra-high risk research. Schizophr Bull 2012; 38: 247–57.Google Scholar
77Velthorst, E, Nieman, DH, Becker, HE, van de Fliert, R, Dingemans, PM, Klaassen, R, et al. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr Res 2009; 109: 60–5.Google Scholar
78Van't Wout, M, Aleman, A, Bermond, B, Kahn, RS. No words for feelings: alexithymia in schizophrenia patients and first-degree relatives. Compr Psychiatry 2007; 48: 27–33.Google Scholar
Figure 0

Table 1 Demographic details for sample 1

Figure 1

Table 2 Demographic details for sample 2

Figure 2

Fig. 1 Differences in positive and negative affect in samples 1 and 2.

Bars in each graph represent standard error. SZ, individuals with schizophrenia; CHR, individuals at clinical high risk for psychosis.
Figure 3

Table 3 Omnibus ANOVA and post hoc results for group affect differences

Figure 4

Fig. 2 Differences in discrete emotions in samples 1 and 2.

In sample 1, group differences for joy and surprise did not meet multiple testing correction criteria. SZ, individuals with schizophrenia; CHR, individuals at clinical high risk for psychosis.
Figure 5

Table 4 Omnibus ANOVAs and post hoc results for discrete trait emotions

Figure 6

Fig. 3 Correlations between affect, clinical symptoms and functioning in samples 1 and 2.

Pos, positive; Neg, negative; Emo, affect; SAPS, Scale for the Assessment of Positive Symptoms; SANS, Scale for the Assessment of Negative Symptoms; GAF, Global Assessment of Functioning; SIPS, Structured Interview for Prodromal Syndromes; Dis, disorganized symptoms; GFS, Global Functioning Scale.
Supplementary material: File

Yee et al. supplementary material

Tables S1-S5

Download Yee et al. supplementary material(File)
File 18.1 KB
Submit a response

eLetters

No eLetters have been published for this article.